Interestingly, systemic anti-citrullinated protein antibodies (ACPA) - highly specific for RA - are also an inducer of osteoclastogenesis and can activate osteoclasts directly, thereby contributing to the local and generalized bone loss seen in RA [135]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.